Pernod Ricard and Brown-Forman confirm merger talks that would create $30 billion global spirits giant amid war-driven market volatility
Pernod Ricard and Brown-Forman have confirmed they are in discussions to combine their businesses in a deal that Reuters Breakingviews values at approximately $30 billion, creating one of the largest transactions in the global consumer goods sector this year. The combination would bring together Pernod Ricard's portfolio — which includes Absolut vodka, Jameson whiskey and Martell cognac — with Brown-Forman's stable of American whiskey brands including Jack Daniel's and Woodford Reserve. The deal sits within a broader surge in global M&A activity: deal volumes announced since January 2026 have reached roughly $1 trillion, a figure only surpassed during the post-pandemic boom of 2021, with the number of transactions valued above $10 billion running at twice the rate of a year ago. The announcement comes in the same week that Estée Lauder confirmed it is in talks with cosmetics rival Puig Brands, valued at approximately $10 billion — pointing to a wave of large-cap consolidation among consumer and lifestyle businesses. The timing is notable: dealmakers are pressing ahead with significant combinations despite acute geopolitical uncertainty driven by the conflict with Iran and Brent crude trading above $114 a barrel. No advisers have been publicly named at this stage, and regulatory approvals — likely to engage competition authorities in multiple jurisdictions given the overlapping global distribution footprints — will be a central feature of any transaction.
Why this matters
A $30 billion cross-border consumer goods merger activates the full suite of corporate advisory work: public M&A (if Brown-Forman's listed shares are acquired), antitrust clearance across the EU, UK (CMA), US (DOJ/FTC), and potentially further jurisdictions where the combined entity would hold dominant market positions in spirits categories. The strategic driver is clear — consolidation in premium spirits has accelerated as both companies face margin pressure from higher energy and transport costs, and a combined entity would gain pricing power with global distributors. The 'why now' trigger is the deregulatory mood in the US under the Trump administration, which has emboldened deal-makers to pursue combinations that might previously have attracted greater regulatory scrutiny. Practice groups across public M&A, competition, tax structuring, and financing will all be engaged on a transaction of this scale.
On the Ground
A trainee on this matter would assist with drafting the conditions precedent (CP) checklist tracking regulatory approvals across multiple jurisdictions, preparing SPA (share purchase agreement) schedules listing required consents, and indexing due diligence reports across the target's global subsidiaries. Board minutes for both the acquirer and target boards approving the transaction and any Rule 2.7 announcement (under the Takeover Code if applicable) would also require trainee support.
Interview prep
Soundbite
A $30bn potential spirits merger at the peak of geopolitical volatility shows PE and strategic M&A appetite is structurally decoupled from macro risk.
Question you might get
“What are the key competition law risks in combining two of the world's largest spirits groups, and which regulatory authorities are most likely to require remedies?”
Full answer
Pernod Ricard and Brown-Forman have confirmed talks on a roughly $30 billion combination that would reshape the global premium spirits industry. For law firms, this creates immediate demand for public M&A, competition clearance, and cross-border tax structuring advice across at least three major jurisdictions. It fits the broader pattern of 2026 M&A surging to $1 trillion globally despite Iran war-driven market volatility — strategic buyers appear unwilling to wait for geopolitical clarity. Antitrust exposure is the key risk: the combined entity would hold leading positions in whiskey, cognac, and vodka simultaneously, making multi-jurisdictional merger control the most contested part of any approval process. This suggests the CMA and European Commission will both take a close look, sustaining advisory mandates well into 2027.
My notes
saved